These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 34354687)

  • 1. Viral UL8 Is Involved in the Antiviral Activity of Oleanolic Acid Against HSV-1 Infection.
    Shan T; Ye J; Jia J; Wang Z; Jiang Y; Wang Y; Wang Y; Zheng K; Ren Z
    Front Microbiol; 2021; 12():689607. PubMed ID: 34354687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oleanolic Acid Derivative AXX-18 Exerts Antiviral Activity by Inhibiting the Expression of HSV-1 Viral Genes UL8 and UL52.
    Wang Z; Jia J; Jiang Y; Li F; Wang Y; Song X; Qin S; Wang Y; Zheng K; Hu B; Cheng Y; Ren Z
    Viruses; 2022 Jun; 14(6):. PubMed ID: 35746758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lupeol impairs herpes simplex virus type 1 replication by inhibiting the promoter activity of the viral immediate early gene α0.
    Ye J; Wang Z; Jia J; Li F; Wang Y; Jiang Y; Wang Y; Ren Z; Pu H
    Acta Virol; 2021; 65(3):254-263. PubMed ID: 34565153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ginkgolic Acid Inhibits Herpes Simplex Virus Type 1 Skin Infection and Prevents Zosteriform Spread in Mice.
    Bhutta MS; Shechter O; Gallo ES; Martin SD; Jones E; Doncel GF; Borenstein R
    Viruses; 2021 Jan; 13(1):. PubMed ID: 33435520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral bioavailability and in vivo efficacy of the helicase-primase inhibitor BILS 45 BS against acyclovir-resistant herpes simplex virus type 1.
    Duan J; Liuzzi M; Paris W; Liard F; Browne A; Dansereau N; Simoneau B; Faucher AM; Cordingley MG
    Antimicrob Agents Chemother; 2003 Jun; 47(6):1798-804. PubMed ID: 12760851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2.
    Chono K; Katsumata K; Kontani T; Kobayashi M; Sudo K; Yokota T; Konno K; Shimizu Y; Suzuki H
    J Antimicrob Chemother; 2010 Aug; 65(8):1733-41. PubMed ID: 20534624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Harringtonine Inhibits Herpes Simplex Virus Type 1 Infection by Reducing Herpes Virus Entry Mediator Expression.
    Liu Y; You Q; Zhang F; Chen D; Huang Z; Wu Z
    Front Microbiol; 2021; 12():722748. PubMed ID: 34531841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral activity of PHA767491 against human herpes simplex virus in vitro and in vivo.
    Hou J; Zhang Z; Huang Q; Yan J; Zhang X; Yu X; Tan G; Zheng C; Xu F; He S
    BMC Infect Dis; 2017 Mar; 17(1):217. PubMed ID: 28320320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of gramicidin, a topical contraceptive and antimicrobial agent with anti-HIV activity, against herpes simplex viruses type 1 and 2 in vitro.
    Bourinbaiar AS; Coleman CF
    Arch Virol; 1997; 142(11):2225-35. PubMed ID: 9672588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new promising candidate to overcome drug resistant herpes simplex virus infections.
    Zinser E; Krawczyk A; Mühl-Zürbes P; Aufderhorst U; Draßner C; Stich L; Zaja M; Strobl S; Steinkasserer A; Heilingloh CS
    Antiviral Res; 2018 Jan; 149():202-210. PubMed ID: 29155164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flexible nano-liposomes-encapsulated recombinant UL8-siRNA (r/si-UL8) based on bioengineering strategy inhibits herpes simplex virus-1 infection.
    Pei J; Tian Y; Dang Y; Ye W; Liu X; Zhao N; Han J; Yang Y; Zhou Z; Zhu X; Zhang H; Ali A; Li Y; Zhang F; Lei Y; Qian A
    Antiviral Res; 2024 Aug; 228():105936. PubMed ID: 38908520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High conservation of herpes simplex virus UL5/UL52 helicase-primase complex in the era of new antiviral therapies.
    Collot M; Rouard C; Brunet C; Agut H; Boutolleau D; Burrel S
    Antiviral Res; 2016 Apr; 128():1-6. PubMed ID: 26826441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of herpes simplex virus replication by a 2-amino thiazole via interactions with the helicase component of the UL5-UL8-UL52 complex.
    Spector FC; Liang L; Giordano H; Sivaraja M; Peterson MG
    J Virol; 1998 Sep; 72(9):6979-87. PubMed ID: 9696789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acyclovir Sensitivity and Neurovirulence of Herpes Simplex Virus Type 1 with Amino Acid Substitutions in the Viral Thymidine Kinase Gene, Which Were Detected in the Patients with Intractable Herpes Simplex Encephalitis Previously Reported.
    Inagaki T; Satoh M; Fujii H; Yamada S; Shibamura M; Yoshikawa T; Harada S; Takeyama H; Saijo M
    Jpn J Infect Dis; 2018 Sep; 71(5):343-349. PubMed ID: 29848849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic activity of amenamevir (ASP2151) with nucleoside analogs against herpes simplex virus types 1 and 2 and varicella-zoster virus.
    Chono K; Katsumata K; Suzuki H; Shiraki K
    Antiviral Res; 2013 Feb; 97(2):154-60. PubMed ID: 23261844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The UL8 subunit of the helicase-primase complex of herpes simplex virus promotes DNA annealing and has a high affinity for replication forks.
    Bermek O; Weller SK; Griffith JD
    J Biol Chem; 2017 Sep; 292(38):15611-15621. PubMed ID: 28743747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral activity of a selective ribonucleotide reductase inhibitor against acyclovir-resistant herpes simplex virus type 1 in vivo.
    Duan J; Liuzzi M; Paris W; Lambert M; Lawetz C; Moss N; Jaramillo J; Gauthier J; Déziel R; Cordingley MG
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1629-35. PubMed ID: 9660995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profile of anti-herpetic action of ASP2151 (amenamevir) as a helicase-primase inhibitor.
    Yajima M; Yamada H; Takemoto M; Daikoku T; Yoshida Y; Long T; Okuda T; Shiraki K
    Antiviral Res; 2017 Mar; 139():95-101. PubMed ID: 28027917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The UL8 subunit of the herpes simplex virus helicase-primase complex is required for efficient primer utilization.
    Sherman G; Gottlieb J; Challberg MD
    J Virol; 1992 Aug; 66(8):4884-92. PubMed ID: 1321275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Herpes simplex virus latency, reactivation, and a new antiviral therapy for herpetic keratitis].
    Shimomura Y
    Nippon Ganka Gakkai Zasshi; 2008 Mar; 112(3):247-64; discussion 265. PubMed ID: 18411713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.